Debt-to-equity of Regen BioPharma Inc from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
ratio: x
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's debt by its shareholder equity.
Summary
Regen BioPharma Inc quarterly Debt-to-equity in x history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Regen BioPharma Inc Debt-to-equity for the quarter ending 31 Dec 2025 was -1.04x, a 0.46% decline year-over-year.
Debt-to-equity, Quarterly (x)
Debt-to-equity, YoY Quarterly Change (%)

Regen BioPharma Inc Quarterly Debt-to-equity (x)

Period Value YoY Chg Change % Date
Q4 2025 -1.04x -0x -0.46% 31 Dec 2025
Q3 2025 -1.04x -0.01x -0.49% 30 Sep 2025
Q2 2025 -1.03x +0.01x +0.75% 30 Jun 2025
Q1 2025 -1.03x +0.01x +1.3% 31 Mar 2025
Q4 2024 -1.03x +0.03x +2.7% 31 Dec 2024
Q3 2024 -1.03x +0.04x +4% 30 Sep 2024
Q2 2024 -1.04x +0.03x +3.1% 30 Jun 2024
Q1 2024 -1.05x +0.03x +3.1% 31 Mar 2024
Q4 2023 -1.06x -0.04x -3.5% 31 Dec 2023
Q3 2023 -1.07x -0.05x -4.7% 30 Sep 2023
Q2 2023 -1.07x -0.04x -4.1% 30 Jun 2023
Q1 2023 -1.08x -0.04x -4.2% 31 Mar 2023
Q4 2022 -1.02x +0.06x +5.9% 31 Dec 2022
Q3 2022 -1.03x +0.06x +5.2% 30 Sep 2022
Q2 2022 -1.03x +0.03x +3% 30 Jun 2022
Q1 2022 -1.04x -0.02x -1.5% 31 Mar 2022
Q4 2021 -1.09x -0.17x -19% 31 Dec 2021
Q3 2021 -1.08x -0.16x -18% 30 Sep 2021
Q2 2021 -1.06x -0.14x -15% 30 Jun 2021
Q1 2021 -1.02x -0.09x -9.3% 31 Mar 2021
Q4 2020 -0.92x +0.09x +8.9% 31 Dec 2020
Q3 2020 -0.92x +0.09x +9% 30 Sep 2020
Q2 2020 -0.93x +0.09x +8.7% 30 Jun 2020
Q1 2020 -0.93x +0.1x +9.2% 31 Mar 2020
Q4 2019 -1.01x +0.05x +4.8% 31 Dec 2019
Q3 2019 -1.01x +0.08x +7.1% 30 Sep 2019
Q2 2019 -1.01x +0.11x +9.7% 30 Jun 2019
Q1 2019 -1.03x +0.14x +12% 31 Mar 2019
Q4 2018 -1.06x +0.15x +13% 31 Dec 2018
Q3 2018 -1.09x +0.23x +18% 30 Sep 2018
Q2 2018 -1.12x +0.34x +23% 30 Jun 2018
Q1 2018 -1.16x +0.55x +32% 31 Mar 2018
Q4 2017 -1.21x +0.7x +37% 31 Dec 2017
Q3 2017 -1.32x +0.39x +23% 30 Sep 2017
Q2 2017 -1.46x +0.5x +26% 30 Jun 2017
Q1 2017 -1.72x +2.56x +60% 31 Mar 2017
Q4 2016 -1.91x -5x -162% 31 Dec 2016
Q3 2016 -1.71x -13.99x -114% 30 Sep 2016
Q2 2016 -1.97x -19.01x -112% 30 Jun 2016
Q1 2016 -4.28x -4.16x -3468% 31 Mar 2016
Q4 2015 3.09x +3.18x 31 Dec 2015
Q3 2015 12.28x 30 Sep 2015
Q2 2015 17.04x 30 Jun 2015
Q1 2015 -0.12x 31 Mar 2015
Q4 2014 -0.09x 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.